Interaction of Abl Tyrosine Kinases with SOCS3 Impairs Its Suppressor Function in Tumorigenesis

Riyue Feng1, Xuefei Wang2, Jianning Li2

  • 1CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing 100101, China; Institute of Physical Science and Information Technology, Anhui University, Hefei 230601, China.

Neoplasia (New York, N.Y.)
|September 22, 2018
PubMed

Insights

Suppressor of cytokine signaling 3 (SOCS3) is tyrosine phosphorylated by c-Abl, impairing its tumor-suppressive function. This phosphorylation is crucial for cancer cell survival and growth, revealing new insights into Abl kinase oncogenic mechanisms.

Area of Science:

  • Oncogenesis
  • Signal Transduction
  • Molecular Biology

Background:

  • Suppressor of cytokine signaling 3 (SOCS3) plays a role in Bcr-Abl-induced tumorigenesis.
  • The precise interaction and regulation mechanisms between SOCS3 and Abl kinases are not fully understood.
  • c-Abl kinase is a critical factor in tumorigenesis.

Purpose of the Study:

  • To investigate whether SOCS3 is regulated by c-Abl-dependent phosphorylation.
  • To elucidate the interaction between SOCS3 and Abl kinases.

Main Methods:

  • Co-immunoprecipitation assays to study protein interactions.
  • Tyrosine phosphorylation assays.
  • In vitro kinase assays.
  • Cell apoptosis assays.
  • Xenograft tumor growth studies in nude mice.

Main Results:

  • SOCS3 interacts with Bcr-Abl, v-Abl, and c-Abl kinases via the Abl kinase SH1 domain.
  • SOCS3 is tyrosine phosphorylated by c-Abl, which impairs its ability to suppress JAK8+72 activity.
  • Disruption of SOCS3 tyrosine phosphorylation promotes apoptosis in c-Abl-expressing cells and inhibits tumor growth in vivo.

Conclusions:

  • SOCS3 is tyrosine phosphorylated by c-Abl, and this modification is essential for the survival and tumorigenesis of specific cancer cells.
  • These findings offer new perspectives on the oncogenic functions of Abl kinases.

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
18.7K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.1K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

4.5K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.1K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
539
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
477